These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6516792)

  • 1. Platelet aggregation and thromboxane B2 formation after ethanol abuse: is there a relationship to stroke?
    Hillbom ME; Kangasaho M; Hjelm-Jäger M
    Acta Neurol Scand; 1984 Dec; 70(6):432-7. PubMed ID: 6516792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ethanol on platelet thromboxane formation after ethanol withdrawal in chronic alcoholics: an in vitro study.
    Neiman J
    Res Exp Med (Berl); 1988; 188(3):175-81. PubMed ID: 3420300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet thromboxane formation capacity after ethanol withdrawal in chronic alcoholics.
    Hillbom M; Neiman J
    Haemostasis; 1988; 18(3):170-8. PubMed ID: 3141251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of 2, 3-dinor-6-keto prostaglandin F1 alpha and platelet thromboxane formation during ethanol withdrawal in alcoholics.
    Neiman J; Hillbom M; Benthin G; Anggård EE
    J Clin Pathol; 1987 May; 40(5):512-5. PubMed ID: 3584500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composition of platelet phosphatidylinositol and phosphatidylcholine after ethanol withdrawal.
    Neiman J; Curstedt T; Cronholm T
    Thromb Res; 1987 Apr; 46(2):295-301. PubMed ID: 3603426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopathy in preleukaemia: association with a defect of thromboxane A2 activity.
    Russell NH; Keenan JP; Bellingham AJ
    Br J Haematol; 1979 Mar; 41(3):417-25. PubMed ID: 570847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin, thromboxane A2 interactions in haemostasis and thrombosis.
    Moncada S; Amezcua JL
    Haemostasis; 1979; 8(3-5):252-65. PubMed ID: 389758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet function defects in chronic alcoholism.
    Mikhailidis DP; Jenkins WJ; Barradas MA; Jeremy JY; Dandona P
    Br Med J (Clin Res Ed); 1986 Sep; 293(6549):715-8. PubMed ID: 3094624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2.
    Nishizawa EE; Williams DJ; Connell CL
    Thromb Res; 1983 May; 30(3):289-96. PubMed ID: 6868025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal.
    Neiman J; Rand ML; Jakowec DM; Packham MA
    Thromb Res; 1989 Nov; 56(3):399-405. PubMed ID: 2617478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
    Mais DE; Kochel PJ; Saussy DL; Halushka PV
    Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
    Johnson GJ; Dunlop PC; Leis LA; From AH
    Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet thromboxane formation and bleeding time is influenced by ethanol withdrawal but not by cigarette smoking.
    Hillbom M; Muuronen A; Löwbeer C; Anggård E; Beving H; Kangasaho M
    Thromb Haemost; 1985 Jun; 53(3):419-22. PubMed ID: 4049313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Byssinosis: thromboxane release from human platelets by cotton dust and bract extracts.
    Mundie TG; Ainsworth SK
    Arch Environ Health; 1985; 40(3):165-9. PubMed ID: 4026387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal platelet response to thromboxane A2.
    Wu KK; Le Breton GC; Tai HH; Chen YC
    J Clin Invest; 1981 Jun; 67(6):1801-4. PubMed ID: 6263954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM; Böger RH; Galland A; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.
    Narumiya S; Okuma M; Ushikubi F
    Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.